Cerus Endovascular, now part of Stryker

Cerus Endovascular, now part of Stryker, is a medical device company that specializes in neurointerventional solutions for treating intracranial aneurysms. The company focuses on designing and developing advanced devices, including the CE Mark-approved Contour Neurovascular System and the Neqstent Coil Assisted Flow Diverter. These products are aimed at providing effective intrasaccular aneurysm therapy. As part of Stryker’s Neurovascular division, Cerus Endovascular enhances the treatment options available for neurovascular specialists and healthcare providers. Their devices are utilized in minimally invasive procedures to address complex aneurysm cases, particularly wide-neck bifurcated aneurysms. This integration supports Stryker’s mission to improve healthcare outcomes globally through innovative medical technologies.

• Employees 12
• Founded 2014
• Total Funding $19000000